Laboratory of Vaccines and Immunotherapeutics (VAKSIN) was established in June 2011 as a result from the restructuring process of Institute of Bioscience (IBS). The Laboratory focuses on R&D and provides services in biotechnology, specifically in the area of vaccines and diagnostics, immunotherapeutics, as well as probiotic and prebiotic technology for the treatment of common and emerging diseases with social and economic impact in animals and humans.

With a team of committed, fully trained and experienced researchers and personnel armed with the necessary expertise, the Laboratory aims to develop ideal vaccines, new and innovative therapies as well as novel probiotics and prebiotics for the advancement of human and animal health globally.